Want to track LRMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Larimar Therapeutics Inc. (LRMR) Statistics
Valuation metrics
Market Cap 277.37M
Enterprise value 189.64M
Trailing P/E (ttm) -1.34
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) -
Price/Book (mrq) 2.18
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 867.6K
Average volume (90 days) 1.28M
Price summary
52-Week low 1.92
52-Week high 6.42
Beta -
50-Day moving average 3.63
200-Day moving average 4.11
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 29 May 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.04%
Return on equity -1.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.66
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 4.7%
Book value per share (mrq) 1.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
